Sernova (SVA) Competitors C$0.17 -0.02 (-8.11%) As of 10/10/2025 03:21 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock SVA vs. TH, BCT, IPA, HBP, SCYB, COM, NVH, IGX, MDNA, and PDPShould you be buying Sernova stock or one of its competitors? The main competitors of Sernova include Theratechnologies (TH), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), and Pediapharm (PDP). These companies are all part of the "biotechnology" industry. Sernova vs. Its Competitors Theratechnologies BriaCell Therapeutics ImmunoPrecise Antibodies Helix BioPharma Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics Pediapharm Theratechnologies (TSE:TH) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment. Does the media favor TH or SVA? In the previous week, Theratechnologies' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score. Company Overall Sentiment Theratechnologies Neutral Sernova Neutral Is TH or SVA more profitable? Sernova has a net margin of 0.00% compared to Theratechnologies' net margin of -3.75%. Sernova's return on equity of 473.85% beat Theratechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Theratechnologies-3.75% 14.30% 5.15% Sernova N/A 473.85%-119.26% Which has stronger valuation and earnings, TH or SVA? Theratechnologies has higher revenue and earnings than Sernova. Theratechnologies is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTheratechnologiesC$84.38M2.44-C$1.96M-C$0.19-23.53SernovaN/AN/A-C$35.70M-C$0.05-3.40 Do insiders & institutionals hold more shares of TH or SVA? 0.5% of Theratechnologies shares are held by institutional investors. Comparatively, 0.0% of Sernova shares are held by institutional investors. 1.2% of Theratechnologies shares are held by company insiders. Comparatively, 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts prefer TH or SVA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Theratechnologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00Sernova 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, TH or SVA? Theratechnologies has a beta of 0.256166, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, Sernova has a beta of 0.611998, meaning that its stock price is 39% less volatile than the S&P 500. SummaryTheratechnologies and Sernova tied by winning 6 of the 12 factors compared between the two stocks. Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSernovaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$55.88MC$153.71MC$6.10BC$9.47BDividend Yield7.86%3.81%5.67%6.48%P/E Ratio-3.4095.4685.2726.27Price / SalesN/A6,044.17612.7812.91Price / Cash6.1513.1938.5083.29Price / Book-3.98109.9012.725.74Net Income-C$35.70M-C$90.99MC$3.30BC$301.20M7 Day Performance-10.53%0.09%0.94%-0.62%1 Month Performance-8.11%5.43%6.34%4.42%1 Year Performance-34.62%718.58%80.41%38.35% Sernova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASernovaN/AC$0.17-8.1%N/A-34.6%C$55.88MN/A-3.401,959Gap DownTHTheratechnologiesN/AC$4.47-4.9%N/A+155.4%C$205.53MC$84.38M-23.53103Gap DownBCTBriaCell TherapeuticsN/AC$10.60-3.8%N/A+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownHBPHelix BioPharmaN/AC$1.69+6.3%N/A+140.0%C$129.08MN/A-1.649High Trading VolumeSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$0.98-1.0%N/A-57.5%C$81.74MN/A-6.1320PDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/A Related Companies and Tools Related Companies Theratechnologies Alternatives BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Helix BioPharma Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Novoheart Alternatives IntelGenx Technologies Alternatives Medicenna Therapeutics Alternatives Pediapharm Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:SVA) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
